Evaluation of a Functional Training Program in Primary Health Care (VIVEactive)

October 25, 2019 updated by: Sara B. Ponte, Unidade de Saude da Ilha de Sao Miguel

VIVE Active: avaliação de um Programa de Treino Funcional Nos Cuidados de saúde primários - Estudo Quasi-experimental

Sedentarism is the fourth risk factor for worldwide mortality and morbility. Considering the high prevalence of sedentarism (57.0%) and obesity (30.5%) in Azores islands (Portugal), local primary health care (PHC) services should support the implementation of complementary interventions and the development of medical research in the area of active lifestyle promotion.

This study aims to evaluate the feasibility and effectiveness of a 6-months functional training program (FTP), which includes a group nutrition counseling, in sedentary users of Ponta Delgada Health Center (PDHC), compared to a waiting list control.

Study Overview

Status

Unknown

Conditions

Detailed Description

This work will be a prospective, longitudinal, quasi-experimental study, with an experimental and a waiting list control group. Here, the investigators aim to test the feasibility and effectiveness of a 6-months functional training program in sedentary users of PDHC. The recruitment of participants will be held in PDHC by health professionals (e.g., family medicine doctors, nurses, nutritionists, psychologists, etc). Participants will be allocated into two groups (experimental and waiting list control groups). After signed informed consent and baseline measures, experimental group will conduct a 6-months functional training program (FTP), which comprises functional training sessions and group nutrition counseling. In every session, it will be evaluated the participants' adherence and theirs perceived enjoyment and exertion. The other outcomes (primary and secondary) will be analyzed through a face-to-face contact, in three different moments: baseline (T0), post-intervention (at month 6, T1) and 6-month follow-up (at month 12, T2). The control group will not participate in any specific intervention, but will receive the FTP after the experimental period. An intention-to-treat and per protocol analysis will be performed to analyze intervention effectiveness and efficacy.

Study Type

Interventional

Enrollment (Anticipated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Azores
      • Ponta Delgada, Azores, Portugal, 9500-354
        • Centro de Saúde de Ponta Delgada (Unidade de Saúde da Ilha de São Miguel)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Sedentary (<150 minutes of moderate-intensity PA per week or <75 minutes of vigorous-intensity PA) users of Health Center of Ponta Delgada.

Exclusion Criteria:

  • Users with a medical contraindications to moderate-to-vigorous intensity physical activity, such as: unstable angina; deep vein thrombosis; recent thromboembolism or embolism; acute systemic infection or fever; atrioventricular block of 2nd grade or higher (without pacemaker); negative deflection of the ST segment deflection of the ST segment > 2 mm; severe neuro-musculoskeletal dysfunction; severe mitral or aortic insufficiency or stenosis without adequate treatment; decompensated heart failure; resting heart rate above 100 bpm; other decompensated metabolic disorders; pericarditis or acute myocarditis; uncontrolled arrhythmia; uncontrolled resting hypertension (SBP ≥ 180 or DBP ≥ 110); orthostatic hypotension with a fall in SBP> 20 mmHg or uncontrolled diabetes.
  • Users with physical and/or mental disabilities or
  • Pregnant women.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Functional Training Program

Functional training program (FTP) will last for 6 months and will include:

  1. Functional training sessions (each 45-minutes long, twice a week);
  2. Group nutrition counseling (each 90-minutes long, in three different moments throughout the intervention: week 1, 12 and 20).

Functional training program (FTP) include:

  1. Functional training sessions will be oriented by graduates or masters in sport with the supervision of a sports medicine doctor;
  2. Group nutrition counseling, in the form of healthy cooking classes direct by nutritionists with the support of culinary students.
No Intervention: Waiting list control group
Participants will not participate in any specific intervention, but will receive the FTP after the experimental period (6 months).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in hand grip strength
Time Frame: T0, baseline; T1, post-intervention (at month 6); and T2, 6-month follow-up (at month 12)
Hand grip strength will be evaluated while the participant is in a sitting position with shoulders adducted and neutrally rotated, elbow flexed at 90°, forearm in neutral and wrist between 0 and 30° of extension. The test will be repeated 3 times with the dominant hand, and maximum reading will be taken.
T0, baseline; T1, post-intervention (at month 6); and T2, 6-month follow-up (at month 12)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adherence to the functional training program
Time Frame: Up to 6 months

Proportion of adherence to the functional training program will be calculated by the average of adherence of each participant. The adherence of each participant will be quantified by the relationship between the sessions attended and the total number of sessions scheduled over the 6 months.

Participants' satisfaction levels will be measured by 10-items questionnaire, on a five point Likert scale from 1 (displeased) to 5 (very satisfied).

Up to 6 months
Perceived enjoyment
Time Frame: Up to 6 months
Perceived enjoyment of the functional training program will be measured biweekly by a scale rated from 1 (very unpleasant) to 5 (very enjoyable).
Up to 6 months
Perceived exertion
Time Frame: Up to 6 months
Perception exertion the functional training program will be measured biweekly by the modified Borg scale. In this instrument, 11 items are evaluated, with a score of 0 to 10 points, where 0 equals the minimum effort and 10 the maximum that they can perform.
Up to 6 months
Participants' satisfaction
Time Frame: T1, Post-intervention (at month 6)
Participant's satisfaction levels will be measured by 10-items questionnaire, on a five point Likert scale from 1 (displeased) to 5 (very satisfied).
T1, Post-intervention (at month 6)
Change in body mass index
Time Frame: T0, baseline; T1, post-intervention (at month 6); and T2, 6-month follow-up (at month 12)
Weight (kilograms) and height (meters) will be combined to report BMI in kg/m^2.
T0, baseline; T1, post-intervention (at month 6); and T2, 6-month follow-up (at month 12)
Change in waist circumference
Time Frame: T0, baseline; T1, post-intervention (at month 6); and T2, 6-month follow-up (at month 12)
Waist circumference in centimeters.
T0, baseline; T1, post-intervention (at month 6); and T2, 6-month follow-up (at month 12)
Change in body fat
Time Frame: T0, baseline; T1, post-intervention (at month 6); and T2, 6-month follow-up (at month 12)
Measured by bioelectrical impedance analysis.
T0, baseline; T1, post-intervention (at month 6); and T2, 6-month follow-up (at month 12)
Change in body lean mass
Time Frame: T0, baseline; T1, post-intervention (at month 6); and T2, 6-month follow-up (at month 12)
Measured by bioelectrical impedance analysis.
T0, baseline; T1, post-intervention (at month 6); and T2, 6-month follow-up (at month 12)
Change in systolic and diastolic blood pressure
Time Frame: T0, baseline; T1, post-intervention (at month 6); and T2, 6-month follow-up (at month 12)
Resting systolic and diastolic blood pressure.
T0, baseline; T1, post-intervention (at month 6); and T2, 6-month follow-up (at month 12)
Change in fast blood glycemia
Time Frame: T0, baseline; T1, post-intervention (at month 6); and T2, 6-month follow-up (at month 12)
Fast blood glycemia (mg/dL).
T0, baseline; T1, post-intervention (at month 6); and T2, 6-month follow-up (at month 12)
Change in HbA1c
Time Frame: T0, baseline; T1, post-intervention (at month 6); and T2, 6-month follow-up (at month 12)
HbA1c (%) reflects the average plasma glucose over the previous 8 to 12 weeks.
T0, baseline; T1, post-intervention (at month 6); and T2, 6-month follow-up (at month 12)
Change in blood lipid profile
Time Frame: T0, baseline; T1, post-intervention (at month 6); and T2, 6-month follow-up (at month 12)
Total cholesterol, LDL cholesterol, HDL cholesterol and triglycerides.
T0, baseline; T1, post-intervention (at month 6); and T2, 6-month follow-up (at month 12)
Change in chronic pain
Time Frame: T0, baseline; T1, post-intervention (at month 6); and T2, 6-month follow-up (at month 12)
Brief Pain Inventory (BPI) will assess the average pain at rest, using a numerical (0-10) rating scale on the BPI Short Form. A higher score indicates worse pain (10 is "worst pain imaginable") and zero indicates 'no pain at all'.
T0, baseline; T1, post-intervention (at month 6); and T2, 6-month follow-up (at month 12)
Change in medication dependence
Time Frame: T0, baseline; T1, post-intervention (at month 6); and T2, 6-month follow-up (at month 12)
Number of pills ingested per day (includes antihypertensives, oral antidiabetics, insulin (injected units), analgesics, anti-inflammatory drugs, psychotropic drugs and antidyslipidemic).
T0, baseline; T1, post-intervention (at month 6); and T2, 6-month follow-up (at month 12)
Change in nicotine dependence
Time Frame: T0, baseline; T1, post-intervention (at month 6); and T2, 6-month follow-up (at month 12)

Fagerström Test for Nicotine Dependence (FTND) will be applied only in smokers participants.

FTND is a 6-item self-report measure of nicotine dependence derived from the Fagerström Tolerance Questionnaire, which comprises yes/no options (scored from 0 to 1) and multiple-choice items (scored from 0 to 3). The items are summed to yield a total score of 0-10. The higher the total Fagerström score, the more intense is the patient's physical dependence on nicotine.

T0, baseline; T1, post-intervention (at month 6); and T2, 6-month follow-up (at month 12)
Change in health-related quality of life
Time Frame: T0, baseline; T1, post-intervention (at month 6); and T2, 6-month follow-up (at month 12)
The health-related quality of life questionaire EQ-5D-5L is a standardised self-report measure of health status developed by the EuroQol Group. It consists of the descriptive system and the EQ Visual Analogue scale. The descriptive system comprises 5 dimensions, namely mobility, self care, usual activities, pain/discomfort, anxiety/depression.
T0, baseline; T1, post-intervention (at month 6); and T2, 6-month follow-up (at month 12)
Change in perceived stress
Time Frame: T0, baseline; T1, post-intervention (at month 6); and T2, 6-month follow-up (at month 12)
Perceived Stress Scale (PSS 10), validated for portuguese population, is a self-report scale with 10 items on daily hassles and the current feeling of being able to handle problems that need to be addressed. It is a five-point Likert scale ranging from 0 (never) to 4 (very often). This questionnaire is widely used to measure perceived stress and has adequate internal and test-retest reliability.
T0, baseline; T1, post-intervention (at month 6); and T2, 6-month follow-up (at month 12)
Change in psychological distress
Time Frame: T0, baseline; T1, post-intervention (at month 6); and T2, 6-month follow-up (at month 12)
Depression, anxiety stress scale-21 (DASS-21) consists of three 7-item subscales: depression, anxiety, and stress. Participants indicate how much each of 21 items applies to them over the past week on a scale from 0 (did not apply to me at all) to 3 (applied to me very much, or most of the time). This scale has good psychometric properties in both clinical and non-clinical samples. Also, this scale reliably distinguishes between symptoms of anxiety (panic/worry), stress (tension/agitation) and depression (low mood/anhedonia), which are highly comorbid.
T0, baseline; T1, post-intervention (at month 6); and T2, 6-month follow-up (at month 12)
Change in mental well-being
Time Frame: T0, baseline; T1, post-intervention (at month 6); and T2, 6-month follow-up (at month 12)
Warwick-Edinburgh Mental Well-being Scale (WEMWBS) is a 14-item scale, validated and self-report instrument used to assess mental wellbeing in general population. Possible scores range from range from 14-70, with higher scores indicating higher mental well-being.
T0, baseline; T1, post-intervention (at month 6); and T2, 6-month follow-up (at month 12)
Changes in eating habits
Time Frame: T0, baseline; T1, post-intervention (at month 6); and T2, 6-month follow-up (at month 12)
PREDIMED (PREvención con DIeta MEDiterránea) is a questionnaire to assess the adherence to the Mediterranean diet, 0 being the minimum total score and 14 the maximum total score. Higher values represent a higher adherence to the Mediterranean diet.
T0, baseline; T1, post-intervention (at month 6); and T2, 6-month follow-up (at month 12)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sara B. Ponte, MD, Unidade de Saúde da Ilha de São Miguel

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

October 1, 2019

Primary Completion (Anticipated)

December 1, 2020

Study Completion (Anticipated)

September 1, 2021

Study Registration Dates

First Submitted

August 8, 2019

First Submitted That Met QC Criteria

August 13, 2019

First Posted (Actual)

August 15, 2019

Study Record Updates

Last Update Posted (Actual)

October 29, 2019

Last Update Submitted That Met QC Criteria

October 25, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • USISM_01_19

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sedentary Lifestyle

Clinical Trials on Functional Training Program

3
Subscribe